title: Prediagnostic C-peptide and risk of prostate cancer.
authors.affiliation: Cancer Control Research, British Columbia Cancer Agency, 675 West 10th Avenue, Vancouver, British Columbia, Canada V5Z 1L3. mborugian@bccrc.ca
authors.forename: Marilyn J
authors.initials: MJ
authors.lastname: Borugian
authors.forename: John J
authors.initials: JJ
authors.lastname: Spinelli
authors.forename: Zheng
authors.initials: Z
authors.lastname: Sun
authors.forename: Laurence N
authors.initials: LN
authors.lastname: Kolonel
authors.forename: Ingrid
authors.initials: I
authors.lastname: Oakley-Girvan
authors.forename: Michael D
authors.initials: MD
authors.lastname: Pollak
authors.forename: Alice S
authors.initials: AS
authors.lastname: Whittemore
authors.forename: Anna H
authors.initials: AH
authors.lastname: Wu
authors.forename: Richard P
authors.initials: RP
authors.lastname: Gallagher
mesh_terms: D014408:Biomarkers, Tumor / Q000097:blood*; D002096:C-Peptide / Q000097:blood*; D016022:Case-Control Studies; D003687:Dehydroepiandrosterone / Q000097:blood; D042241:Early Diagnosis; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000097:blood / Q000175:diagnosis*; D012044:Regression Analysis; D012307:Risk Factors; D013223:Statistics as Topic; D013739:Testosterone / Q000097:blood
chemical_list: D014408:Biomarkers, Tumor; D002096:C-Peptide; D013739:Testosterone; D003687:Dehydroepiandrosterone